Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003660897 | SCV004376548 | pathogenic | not provided | 2023-03-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SYT2 protein function. ClinVar contains an entry for this variant (Variation ID: 1192313). This missense change has been observed in individual(s) with congenital myasthenic syndrome (PMID: 34037996). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 365 of the SYT2 protein (p.Leu365Pro). |
OMIM | RCV001553805 | SCV001774825 | pathogenic | Congenital myasthenic syndrome 7 | 2021-08-06 | no assertion criteria provided | literature only |